EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines

Yani Wu iD, Fang Cao iD, Jiayin Dai, Zhenli Yang, Yanli Zhu, Dongmei Lin, Xiaocui Bian iD, Yuqin Liu iD

Thoracic Cancer · 2026-08 · 17 (15)

DOI: 10.1111/1759-7714.70366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 04.08.2026. Verfasst von Yani Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cell Resource Center, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences …. Hauptthemen laut MEDLINE: Mesothelioma, Genomics, Transcriptome, Pleural Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences, Science Foundation of Peking University Cancer Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pleural mesothelioma (PM) is an aggressive cancer with limited therapeutic options and poor prognosis, necessitating comprehensive model systems for mechanistic studies and drug discovery.

Methods

Tumor cells were isolated from malignant pleural effusion of PM patients and subjected to primary culture and continuous passaging. Cell lines were successfully established after more than 40 continuous passages in vitro. Cell identification included morphological analysis, species identification, short tandem repeat (STR) profiling, mycoplasma detection, in vitro proliferation assays, in vivo tumorigenicity testing in NOD/SCID mice, and immunohistochemical characterization. Genomic landscapes and transcriptomic profiling were defined by whole‐exome, whole‐genome sequencing, and RNA‐sequencing.

Results

Three Chinese‐derived pleural mesothelioma cell lines (PUMC‐MESO1, PUMC‐MESO3, and PUMC‐MESO4) were successfully established. All three cell lines exhibited epithelioid morphology with adherent growth patterns. Upon subcutaneous transplantation into NOD/SCID mice, PUMC‐MESO1 and PUMC‐MESO4 demonstrated tumorigenicity, while PUMC‐MESO3 remained non‐tumorigenic after 3 months of observation. Histopathological examination confirmed their mesothelioma origin through positive staining for mesothelial markers including calretinin, WT‐1, and D2‐40. Genomic analysis revealed characteristic PM genomic alterations including mutations in BAP1 , NF2, and TP53 , along with CDKN2A deletions. Transcriptomic analyses revealed heterogeneous molecular features among the three cell lines. Although the PUMC‐MESO cell lines displayed distinct clustering patterns relative to the CCLE mesothelioma cohort, each retained transcriptomic similarities to specific established mesothelioma models. Drug sensitivity assays further demonstrated heterogeneous responses to standard therapeutic agents.

Conclusion

This study reports the establishment and characterization of three novel PM cell lines. These models recapitulate key aspects of PM biology, exhibit diverse therapeutic responses, and provide a valuable new resource for investigating disease mechanisms and advancing precision oncology research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MesotheliomaGenomicsTranscriptomePleural NeoplasmsHumansAnimalsMiceMice, SCIDCell Line, TumorMice, Inbred NODMesothelioma, Malignant

Stichwörter der Autor:innen

cell linechemosensitivitymulti‐omicspleural mesotheliomaresource

Autor:innen und Institutionen

  • Department of Pathology, Cell Resource Center, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.

ORCID-Profile: Yani Wu, Fang Cao, Xiaocui Bian, Yuqin Liu

Förderung

  • CAMS Innovation Fund for Medical Sciences
  • Science Foundation of Peking University Cancer Hospital

Zitieren

APA

Wu, Y., Cao, F., Dai, J., Yang, Z., Zhu, Y., Lin, D., Bian, X., & Liu, Y. (2026). Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines. Thoracic Cancer, 17(15). https://doi.org/10.1111/1759-7714.70366

Vancouver

Wu Y, Cao F, Dai J, Yang Z, Zhu Y, Lin D, et al. Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines. Thoracic Cancer. 2026;17(15). doi:10.1111/1759-7714.70366

BibTeX
@article{Wu2026,
  author = {Wu, Yani and Cao, Fang and Dai, Jiayin and Yang, Zhenli and Zhu, Yanli and Lin, Dongmei and Bian, Xiaocui and Liu, Yuqin},
  title = {Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines},
  journal = {Thoracic Cancer},
  year = {2026},
  volume = {17},
  number = {15},
  doi = {10.1111/1759-7714.70366}
}
Kostenlos starten →